Endoscope Reprocessing Device Market Growth Factors, Applications, Regional Analysis, Key Players and Forecasts by 2026


Rising adoption of the innovative automated endoscope reprocessors in the healthcare settings to augment the growth of endoscope reprocessing market

The rise in adoption of endoscope reprocessors in hospitals for infection prevention and control and the emergence of automated endoscope reprocessors (AER) in the healthcare settings is expected to fuel the growth of the global endoscope reprocessing device market over the forecast period. The AERs can enhance the reliability and consistency of endoscope reprocessing by standardizing several important reprocessing steps, thereby reducing the possibility of human error.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1010

The use of AERs reduces exposure of personnel to harmful chemical germicides, thereby minimizing the health problems attributed to reprocessing of endoscopes. Moreover, rising government concerns pertaining to patient safety and strong healthcare infrastructure support are the factors contributing to rise in global endoscope reprocessing device market. For instance, in 2015, the Centers for Disease Control and Prevention (CDC) has asked the Healthcare Infection Control Practices Advisory Committee (HICPAC) to issue guidelines for the improvement of facility-level training to ensure competency for endoscope reprocessing devices.

Key Players

The key players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Soluscope, ENDO-TECHNIK W.Griesat GmbH, Getinge AB, PENTAX Medical, Wassenburg Medical B.V., Steelco S.p.A., Medivators Inc., Johnson & Johnson, and Minntech Corp.

Endoscope reprocessing devices are used in the healthcare settings for the reprocessing procedures of the endoscopes. The endoscope reprocessing devices are used to decontaminate the instruments and devices such as duodenoscopes, endoscope accessories, and others. Endoscope reprocessing devices are Class II devices cleared through the premarket notification by the Food and Drug Administration (FDA). Click To Read More On Endoscope Reprocessing Device Market

The devices are designed to inhibit microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to chemical solutions. Moreover, the endoscope reprocessing devices reduce staff exposure hazards associated with aldehyde-based solutions, thus granting major safety advantage for the adoption and usage of endoscope reprocessing devices.


About Author

Richard is a science and space enthusiast who aims to excel in the field, especially in human anatomical studies. He curates quality pieces for Ace Newz in the science genre.

Comments are closed.